close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Strona główna・Stock List・Nektar Therapeutics
Search

Nektar Therapeutics

Closed

70.33 -2.77

Strong Buy

Price update 6 mar 2026, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

70.33

Max

72.56

Key metrics

By Trading Economics

Income

6.1M

-36M

Sales

615K

12M

EPS

-1.87

Profit margin

-301.289

Employees

61

EBITDA

6.9M

-29M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+82.62% upside

Dividends

By Dow Jones

Next Earnings

12 mar 2026

Market Stats

By TradingEconomics

Market Cap

773M

1.9B

Previous open

73.1

Previous close

70.33

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

0.5949 / 0.7406 Support & Resistance

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 mar 2026, 23:01 UTC

Earnings

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

DJ

Read

5 mar 2026, 21:54 UTC

Earnings

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

DJ

Read

5 mar 2026, 21:35 UTC

Major Market Movers

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

DJ

Read

6 mar 2026, 00:00 UTC

Major News Events

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

DJ

Read

5 mar 2026, 23:46 UTC

Market Talk

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

DJ

Read

5 mar 2026, 23:33 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

DJ

Read

5 mar 2026, 23:27 UTC

Market Talk

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

DJ

Read

5 mar 2026, 22:54 UTC

Market Talk
Earnings

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

DJ

Read

5 mar 2026, 22:50 UTC

Market Talk

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

DJ

Read

5 mar 2026, 22:48 UTC

Earnings

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

DJ

Read

5 mar 2026, 22:46 UTC

Earnings

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

DJ

Read

5 mar 2026, 22:44 UTC

Earnings

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

DJ

Read

5 mar 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

5 mar 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

5 mar 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

5 mar 2026, 21:35 UTC

Earnings

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

DJ

Read

5 mar 2026, 21:32 UTC

Earnings

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

DJ

Read

5 mar 2026, 21:26 UTC

Earnings

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

DJ

Read

5 mar 2026, 21:24 UTC

Earnings

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

DJ

Read

5 mar 2026, 21:23 UTC

Earnings

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

DJ

Read

5 mar 2026, 21:22 UTC

Earnings

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

DJ

Read

5 mar 2026, 21:21 UTC

Earnings

Costco February Digitally-Enabled Sales Rose 21.8% >COST

DJ

Read

5 mar 2026, 21:21 UTC

Earnings

Costco Total Co Comparable Sales for February Rose 7.9% >COST

DJ

Read

5 mar 2026, 21:20 UTC

Earnings

Costco February Net Sales Were $21.69 B >COST

DJ

Read

5 mar 2026, 21:20 UTC

Earnings

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

DJ

Read

5 mar 2026, 21:20 UTC

Earnings

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

DJ

Read

5 mar 2026, 21:19 UTC

Earnings

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

DJ

Read

5 mar 2026, 21:18 UTC

Earnings

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

DJ

Read

5 mar 2026, 21:18 UTC

Earnings

Costco 2Q Same-Store Sales Up 7.4% >COST

DJ

Read

5 mar 2026, 21:15 UTC

Earnings

Costco 2Q EPS $4.58 >COST

DJ

Read

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

82.62% upside

12 Months Forecast

Average 129.86 USD  82.62%

High 165 USD

Low 102 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

8

Buy

0

Hold

0

Sell

Based on 8 analysts giving stock ratings to Nektar Therapeutics - Dist in the past 3 months.

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

988.33

↑ +0.72%

JNJ

Johnson and Johnson

240.32

↑ +0.33%

ABBV

AbbVie Inc

229.95

↓-0.9%

NVS

Novartis AG

159.76

↓-0.49%

AZN

AstraZeneca PLC

194.37

↓-1.51%
help-icon Live chat